Literature DB >> 19585137

Regional metastatic pattern of papillary thyroid carcinoma.

Imdat Yüce1, Sedat Cağli, Ali Bayram, Fatih Karasu, Ercihan Güney.   

Abstract

The objective of the present study was to determine the pattern of lymphatic spread in papillary thyroid carcinoma with clinically positive nodes. Between 1999 and 2008, a total of 48 consecutive patients with clinical evidence of cervical lymph node metastasis of papillary thyroid carcinoma underwent 61 modified radical neck dissections (13 being bilateral) including levels II-VI. All neck dissection specimens were separated during surgery into levels and analysis was done with respect to the levels of neck. T value of tumor and demographic parameters were compared with the number of metastatic nodes with univariate analysis. The median number of pathologic nodes in neck dissection specimen was 7.0. The predominant site of metastasis was level VI (77%), followed by level III (69%), level IV (66%), and level II (46%). Level V showed 34% of nodal metastasis. Seven patients had level VII, and five patients had parapharyngeal lymph node dissections because of lymphatic involvement at these sites. There was no statistically significant correlation between T value, age, sex and the number of histologically positive lymph nodes (P = 0.39, P = 0.91 and P = 0.84, respectively). It was concluded that the high incidence of metastatic disease in levels II through VI supports the recommendation for level II through level VI neck dissection in patient with clinically positive neck disease.

Entities:  

Mesh:

Year:  2009        PMID: 19585137     DOI: 10.1007/s00405-009-1032-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  18 in total

1.  Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery.

Authors:  K Thomas Robbins; Garry Clayman; Paul A Levine; Jesus Medina; Roy Sessions; Ashok Shaha; Peter Som; Gregory T Wolf
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-07

Review 2.  Well differentiated thyroid cancer.

Authors:  N R Caron; O H Clark
Journal:  Scand J Surg       Date:  2004       Impact factor: 2.360

3.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

4.  Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

5.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

6.  Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age.

Authors:  N Wada; K Masudo; H Nakayama; N Suganuma; K Matsuzu; S Hirakawa; Y Rino; M Masuda; T Imada
Journal:  Eur J Surg Oncol       Date:  2007-11-19       Impact factor: 4.424

7.  Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.

Authors:  Ashok R Shaha
Journal:  Laryngoscope       Date:  2004-03       Impact factor: 3.325

8.  Predictive factors of level IIb lymph node metastasis in patients with papillary thyroid carcinoma.

Authors:  Bon Seok Koo; Yeo-Hoon Yoon; Jin-Man Kim; Eun Chang Choi; Young Chang Lim
Journal:  Ann Surg Oncol       Date:  2009-02-18       Impact factor: 5.344

9.  Regional metastases in well-differentiated thyroid carcinoma: pattern of spread.

Authors:  Yoav Yanir; Ilana Doweck
Journal:  Laryngoscope       Date:  2008-03       Impact factor: 3.325

Review 10.  Papillary thyroid cancer: surgical management of lymph node metastases.

Authors:  Nadine R Caron; Orlo H Clark
Journal:  Curr Treat Options Oncol       Date:  2005-07
View more
  7 in total

Review 1.  The extent of lateral lymph node dissection in differentiated thyroid cancer in the N+ neck.

Authors:  S Kumar; C Burgess; R Moorthy
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-22       Impact factor: 2.503

2.  Significance of clearing differentiated thyroid carcinoma lymph node by high-frequency color Doppler ultrasonography.

Authors:  Bing Liu; Huadong Qin; Bin Zhang; Tiefeng Shi; Chuanle Li; Yao Liu; Meiyue Song
Journal:  Oncol Lett       Date:  2016-11-30       Impact factor: 2.967

3.  Regional Node Distribution in Papillary Thyroid Cancer with Microscopic Metastasis.

Authors:  Luis-Mauricio Hurtado-López; Alejandro Ordoñez-Rueda; Felipe-Rafael Zaldivar-Ramírez; Erich Basurto-Kuba
Journal:  J Thyroid Res       Date:  2018-11-01

4.  Should level V be included in lateral neck dissection in treating papillary thyroid carcinoma?

Authors:  Xiao-Jun Zhang; Dan Liu; De-Bin Xu; Ya-Qi Mu; Wen-Kuan Chen
Journal:  World J Surg Oncol       Date:  2013-11-25       Impact factor: 2.754

5.  Parapharyngeal metastases from thyroid cancer: surgical management of two cases with minimally-invasive video-assisted technique.

Authors:  L Giordano; F Pilolli; S Toma; M Bussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-10       Impact factor: 2.124

Review 6.  Level V Clearance in Neck Dissection for Papillary Thyroid Carcinoma: A Need for Homogeneous Studies.

Authors:  Azhar Jan Battoo; Zahoor Ahmad Sheikh; Krishnakumar Thankappan; Abdul Wahid Mir; Altaf Gowhar Haji
Journal:  Int Arch Otorhinolaryngol       Date:  2017-12-13

7.  Clinicopathologic characteristics and outcomes of papillary thyroid carcinoma in younger patients.

Authors:  Yi Lu; Lin Jiang; Chao Chen; Haitao Chen; Qinghua Yao
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.